Mirae Asset Global ETFs Holdings’s Bio-Rad Laboratories Class A BIO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.13M	Buy	+14,068	New	+$3.99M	﹤0.01%	931
2025 Q2	–	Sell	-63	Closed	-$15.3K	–	3031
2025 Q1	$15.3K	Sell	63 -6	-9%	-$1.8K	﹤0.01%	3001
2024 Q4	$22.7K	Sell	69 -13	-16%	-$4.41K	﹤0.01%	2998
2024 Q3	$27.4K	Sell	82 -1,754	-96%	-$557K	﹤0.01%	3000
2024 Q2	$501K	Buy	+1,836	New	+$534K	﹤0.01%	1827

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's BIO Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2026: 14,068 shares worth $4.13M. The stake represents ﹤0.01% of the portfolio and ranks #931 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in BIO as recently as Q1 2025.

Mirae Asset Global ETFs Holdings first reported a position in BIO in Q2 2024 and has held it in 5 quarters since. 401 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Mirae Asset Global ETFs Holdings held 14,068 shares of Bio-Rad Laboratories Class A worth $4.13M as of Q2 2026.
Bio-Rad Laboratories Class A was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
Bio-Rad Laboratories Class A made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #931 holding.
Mirae Asset Global ETFs Holdings first reported a position in Bio-Rad Laboratories Class A in Q2 2024 and has held it in 5 quarters since.
401 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.